CN112166115A - 新型苯二氮杂*衍生物及其用途 - Google Patents

新型苯二氮杂*衍生物及其用途 Download PDF

Info

Publication number
CN112166115A
CN112166115A CN201980035084.3A CN201980035084A CN112166115A CN 112166115 A CN112166115 A CN 112166115A CN 201980035084 A CN201980035084 A CN 201980035084A CN 112166115 A CN112166115 A CN 112166115A
Authority
CN
China
Prior art keywords
compound
alkyl
independently
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980035084.3A
Other languages
English (en)
Chinese (zh)
Inventor
T·朴
S·H·吴
S·金
S·朴
J·崔
D·郑
D·徐
J·李
S·李
S·尹
H·S·李
O·朴
B·徐
M·薛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yintusaili Co ltd
Original Assignee
Yintusaili Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yintusaili Co ltd filed Critical Yintusaili Co ltd
Priority to CN202110592302.2A priority Critical patent/CN113444111A/zh
Publication of CN112166115A publication Critical patent/CN112166115A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201980035084.3A 2018-05-29 2019-05-29 新型苯二氮杂*衍生物及其用途 Pending CN112166115A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110592302.2A CN113444111A (zh) 2018-05-29 2019-05-29 新型苯二氮杂䓬衍生物及其用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862677498P 2018-05-29 2018-05-29
US62/677,498 2018-05-29
PCT/IB2019/000691 WO2019229536A2 (en) 2018-05-29 2019-05-29 Novel benzodiazepine derivatives and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202110592302.2A Division CN113444111A (zh) 2018-05-29 2019-05-29 新型苯二氮杂䓬衍生物及其用途

Publications (1)

Publication Number Publication Date
CN112166115A true CN112166115A (zh) 2021-01-01

Family

ID=68692822

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201980035084.3A Pending CN112166115A (zh) 2018-05-29 2019-05-29 新型苯二氮杂*衍生物及其用途
CN202110592302.2A Pending CN113444111A (zh) 2018-05-29 2019-05-29 新型苯二氮杂䓬衍生物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110592302.2A Pending CN113444111A (zh) 2018-05-29 2019-05-29 新型苯二氮杂䓬衍生物及其用途

Country Status (12)

Country Link
US (2) US11084801B2 (cg-RX-API-DMAC7.html)
EP (1) EP3802546A4 (cg-RX-API-DMAC7.html)
JP (1) JP7465819B2 (cg-RX-API-DMAC7.html)
KR (1) KR102946423B1 (cg-RX-API-DMAC7.html)
CN (2) CN112166115A (cg-RX-API-DMAC7.html)
AU (2) AU2019276833A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020023623A2 (cg-RX-API-DMAC7.html)
CA (1) CA3100141A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092909A1 (cg-RX-API-DMAC7.html)
IL (1) IL278973B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020012718A (cg-RX-API-DMAC7.html)
WO (1) WO2019229536A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117377468A (zh) * 2021-05-27 2024-01-09 融合制药公司 2,6-二氯苯基酯化合物及其用途

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102710962B1 (ko) 2017-07-04 2024-09-27 주식회사 인투셀 절단성 링커를 포함하는 화합물 및 이들의 용도
CN112166115A (zh) 2018-05-29 2021-01-01 尹图赛利有限公司 新型苯二氮杂*衍生物及其用途
EP3873912B1 (en) 2018-10-31 2026-03-25 Intocell, Inc. Fused heterocyclic benzodiazepine derivatives and uses thereof
MX2021008095A (es) * 2019-01-03 2021-08-05 Intocell Inc Compuestos que comprenden un enlazador escindible y sus usos.
EP3906063A4 (en) 2019-01-03 2023-03-01 Intocell, Inc. COMPOUNDS COMPRISING A CLEAVABLE LINKER AND THEIR USES
CN114728075B (zh) * 2019-12-02 2025-10-03 尹图赛利有限公司 与分子缀合相关的组合物和方法
CN115942978A (zh) * 2020-06-26 2023-04-07 尹图赛利有限公司 包含抗b7-h3抗体的抗体-药物缀合物
CN119350387A (zh) * 2022-03-03 2025-01-24 西北工业大学 新型可光催化剪切的羧酸保护基磷酰氧基-4-香豆素基甲基类化合物及其氨基酸衍生物的制备方法
CN119424671A (zh) 2023-08-01 2025-02-14 上海新理念生物医药科技有限公司 含糖基吡啶型连接子的抗体药物偶联物
WO2025262641A1 (en) * 2024-06-19 2025-12-26 Pheon Therapeutics Ltd Antibody drug conjugates that bind cdcp1 and uses thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102186855A (zh) * 2008-10-17 2011-09-14 斯皮罗根有限公司 用于治疗增殖性疾病的非对称的吡咯并苯并二氮杂*-二聚体
WO2014031566A1 (en) * 2012-08-22 2014-02-27 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
WO2016149546A1 (en) * 2015-03-19 2016-09-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
CN107231804A (zh) * 2015-01-14 2017-10-03 百时美施贵宝公司 亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法
CN107428780A (zh) * 2015-01-14 2017-12-01 百时美施贵宝公司 苯并二氮杂*二聚体、其缀合物及制备和使用方法
WO2018053552A2 (en) * 2016-09-19 2018-03-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
CN111278845A (zh) * 2017-07-04 2020-06-12 尹图赛利有限公司 包含可裂解接头的化合物及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843937A (en) 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
CA3014224C (en) 2009-02-05 2022-05-24 Immunogen, Inc. Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives
AU2012322934B2 (en) * 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
KR102384740B1 (ko) * 2013-12-27 2022-04-07 자임워크스 인코포레이티드 약물 접합체를 위한 설폰아마이드-함유 연결 시스템
US10973920B2 (en) 2014-06-30 2021-04-13 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
KR20170128256A (ko) 2015-03-18 2017-11-22 시애틀 지네틱스, 인크. Cd48 항체 및 이의 접합체
EP3458050A1 (en) 2016-05-20 2019-03-27 Abbvie Stemcentrx LLC Anti-dll3 drug conjugates for treating tumors at risk of neuroendocrine transition
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
JP7527787B2 (ja) * 2017-03-24 2024-08-05 シージェン インコーポレイテッド グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体
WO2018195243A1 (en) 2017-04-20 2018-10-25 Immunogen, Inc. Cytotoxic benzodiazepine derivatives and conjugates thereof
GB201714115D0 (en) * 2017-09-04 2017-10-18 Femtogenix Ltd Cytotoxic agents
CN112166115A (zh) 2018-05-29 2021-01-01 尹图赛利有限公司 新型苯二氮杂*衍生物及其用途
EP3873912B1 (en) 2018-10-31 2026-03-25 Intocell, Inc. Fused heterocyclic benzodiazepine derivatives and uses thereof
KR102503143B1 (ko) 2019-03-06 2023-02-24 주식회사 레고켐 바이오사이언스 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도
CN115942978A (zh) 2020-06-26 2023-04-07 尹图赛利有限公司 包含抗b7-h3抗体的抗体-药物缀合物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102186855A (zh) * 2008-10-17 2011-09-14 斯皮罗根有限公司 用于治疗增殖性疾病的非对称的吡咯并苯并二氮杂*-二聚体
WO2014031566A1 (en) * 2012-08-22 2014-02-27 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
CN107231804A (zh) * 2015-01-14 2017-10-03 百时美施贵宝公司 亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法
CN107428780A (zh) * 2015-01-14 2017-12-01 百时美施贵宝公司 苯并二氮杂*二聚体、其缀合物及制备和使用方法
WO2016149546A1 (en) * 2015-03-19 2016-09-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
WO2018053552A2 (en) * 2016-09-19 2018-03-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
CN111278845A (zh) * 2017-07-04 2020-06-12 尹图赛利有限公司 包含可裂解接头的化合物及其用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREW F. DONNELL ET AL.: ""Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads"", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 27, 16 October 2017 (2017-10-16), pages 5267 - 5271 *
DONGLU ZHANG ET AL.: ""Immolation of p‑Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody−Drug Conjugates with Phenol-Containing Payloads"", 《BIOCONJUGATE CHEMISTRY》, vol. 29, 25 January 2018 (2018-01-25), pages 267 - 274 *
MICHAEL L. MILLER ET AL.: ""A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity"", 《MOLECULAR CANCER THERAPEUTICS》, vol. 15, no. 8, 23 May 2016 (2016-05-23), pages 1870 - 1878 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117377468A (zh) * 2021-05-27 2024-01-09 融合制药公司 2,6-二氯苯基酯化合物及其用途

Also Published As

Publication number Publication date
CN113444111A (zh) 2021-09-28
US20190367488A1 (en) 2019-12-05
KR20210003938A (ko) 2021-01-12
EP3802546A2 (en) 2021-04-14
JP7465819B2 (ja) 2024-04-11
KR102946423B1 (ko) 2026-04-01
US20220162190A1 (en) 2022-05-26
EP3802546A4 (en) 2021-12-29
IL278973B1 (en) 2025-03-01
IL278973A (en) 2021-01-31
MX2020012718A (es) 2021-02-16
BR112020023623A2 (pt) 2021-02-17
JP2021525730A (ja) 2021-09-27
CA3100141A1 (en) 2019-12-05
WO2019229536A3 (en) 2020-03-05
AU2023203485B2 (en) 2024-09-19
EA202092909A1 (ru) 2021-04-07
AU2019276833A1 (en) 2020-11-26
IL278973B2 (en) 2025-07-01
WO2019229536A2 (en) 2019-12-05
AU2023203485A1 (en) 2023-07-06
US11807628B2 (en) 2023-11-07
US11084801B2 (en) 2021-08-10

Similar Documents

Publication Publication Date Title
KR102946423B1 (ko) 신규한 벤조다이아제핀 유도체 및 그 용도
AU2023216777C1 (en) Compounds comprising cleavable linker and uses thereof
TW202400137A (zh) 喜樹鹼偶聯物
EP3873912B1 (en) Fused heterocyclic benzodiazepine derivatives and uses thereof
CN113423431A (zh) 包含可裂解接头的化合物及其用途
CN113453726A (zh) 包含可裂解接头的化合物及其用途
CN118414170A (zh) 包含具有极性基团的毒素的抗体药物缀合物及其用途
KR20220108783A (ko) 분자 접합과 관련된 조성물 및 방법
EA046916B1 (ru) Производные бензодиазепина и их применение
EA048717B1 (ru) Производные конденсированного гетероциклического бензодиазепина и их применение

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination